By manipulating TGFβ signaling pathways, researchers may be able to enhance the efficacy of stem cell therapies and promote the differentiation of stem cells into β-cells to improve insulin production and manage hyperglycemia (Brown and Schneyer 2021). The gene discussed is INS; the disease is Hyperglycemia.